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Impact of Left Atrial Volume on Clinical
Outcome in Organic Mitral Regurgitation
Thierry Le Tourneau, MD, David Messika-Zeitoun, MD, Antonio Russo, MD, Delphine Detaint, MD,
Yan Topilsky, MD, Douglas W. Mahoney, MS, Rakesh Suri, MD, DPHIL,
Maurice Enriquez-Sarano, MD
Rochester, Minnesota
Objectives The purpose of this paper was to assess the link between left atrial (LA) volume at diagnosis and outcome of
patients with mitral regurgitation (MR).
Background Left atrial enlargement is a consequence of organic MR, but its association with clinical outcome independently
of MR severity is uncertain.
Methods We prospectively enrolled 492 patients (age 63  15 years, 60% men) in sinus rhythm with organic MR (regur-
gitant volume 68  42 ml/beat) and performed at baseline triple echocardiographic quantitation (MR severity,
LA volume, and left ventricular characteristics). Outcome with medical and surgical management was analyzed.
Results Left atrial volume indexed to body surface area (LA index) was 55  26 ml/m2 (40 ml/m2 in 158 patients, 40
to 59 ml/m2 in 160 patients, and 60 ml/m2 in 174 patients). Under medical management, 5-year survival
was 80  2.9% and cardiac events 28  3%. Adjusting for established predictors of outcome, LA index was in-
dependently associated with survival after diagnosis (hazard ratio [HR]: 1.3 [95% confidence interval (CI): 1.1 to
1.5] per 10 ml/m2 increment, p  0.001). Patients with LA index 60 ml/m2 had lower 5-year survival than
those with no or mild LA enlargement (p  0.0001) and than the rates of survival expected in the U.S. popula-
tion (53  8.6% vs. 76%, p  0.017). Compared with patients with LA index 40 ml/m2, those with LA index
60 ml/m2 had increased mortality (HR: 2.8 [95% CI: 1.2 to 6.5], p  0.016) and cardiac events (HR: 5.2 [95%
CI: 2.6 to 10.9], p  0.0001) with medical management. Mitral surgery was associated with decreased mortality
(HR: 0.46 [95% CI: 0.26 to 0.84], p  0.01) and cardiac events (HR: 0.38 [95% CI: 0.23 to 0.62], p  0.0001)
and after surgery patients with LA index 60 ml/m2 versus 60 ml/m2 did not incur excess mortality or car-
diac events (both p  0.30).
Conclusions In organic MR, LA index at diagnosis predicts long-term outcome, incrementally to known predictors of outcome.
This marker of risk is particularly important because mitral surgery in these patients markedly improves out-
come and restores life expectancy. LA index should be measured in routine clinical practice for risk-stratification
and for clinical decision making in patients with organic MR. (J Am Coll Cardiol 2010;56:570–8) © 2010 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.02.059m
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sitral regurgitation (MR) is frequent and its prevalence
ncreases with age (1). Previous studies in organic MR (due
o intrinsic valve lesions) have shown that patients with
ymptoms or decreased ejection fraction (EF) 60% incur
igh risk with medical management (2) and require mitral
urgery (3,4) but sustain excess mortality post-operatively
elated to their severe presentation (5,6). Therefore, the
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Manuscript received February 17, 2009; revised manuscript received February 4,
010, accepted February 8, 2010.anagement of patients with MR remains debated (3,4).
hereas 1 study advocates a watchful-waiting strategy in
symptomatic severe MR (7), other studies, single- and
ulticenter, suggest that MR causes notable risks, improved
y mitral surgery (8,9), particularly valve repair (9,10). In
iew of this controversy, identification of new criteria
efining high-risk groups is warranted and has potential to
efine management of patients with organic MR.
See page 579
Left atrial (LA) enlargement is a pathophysiologic re-
ponse to volume overload in organic MR, which allows LA
ressure homeostasis (11,12). Left atrial volume measure-
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August 10, 2010:570–8 Left Atrial Volume in Mitral Regurgitationent is now considered superior to LA diameter (13,14),
nd in the general population, larger LA volume has been
ssociated with atrial fibrillation (15), stroke, congestive
eart failure (16), and mortality (17). Left atrial enlarge-
ent was also suggested as predictive of outcome in
schemic or nonischemic cardiomyopathy (18,19). Con-
ersely, in patients with atrial fibrillation (AF), LA volume
rognostic utility is poor (13), which is probably related to
ndependent AF effect on LA enlargement (14). In patients
ith organic MR, LA size is a marker for subsequent AF
14,20,21). However, actual impact of LA volume on
utcome, particularly survival after diagnosis under medical
nd surgical management, and its usefulness in managing
atients with organic MR, are poorly defined. To examine
he hypothesis that LA volume predicts survival indepen-
ently of MR severity, we prospectively enrolled patients
ith chronic organic MR in sinus rhythm and prospectively
erformed triple quantitation of LA volume, MR severity,
nd left ventricular (LV) characteristics to evaluate the
redictive value of LA volume measured at diagnosis on
utcome with medical or surgical management.
ethods
tudy eligibility. Between 1990 and 2000, we prospec-
ively enrolled patients: 1) with at least mild organic MR
intrinsic mitral valve lesions); 2) in sinus rhythm at base-
ine; and 3) in whom triple quantitation of LA volume, LV
olumes, and MR severity was available. Patients with
apillary muscle rupture, functional MR, associated mitral
alve stenosis of any degree, associated aortic or congenital
eart disease, or previous valvular surgery were excluded.
atients with symptoms or decreased EF in the context of
rganic MR were not excluded. The study was approved by
he Mayo Clinic Institutional Review Board.
oppler-echocardiographic measurements. Comprehen-
ive Doppler and 2-dimensional echocardiography provided
ata prospectively recorded and used as measured at diag-
osis without alteration. Patients underwent triple quanti-
ation of LV characteristics (volumes and mass), LA vol-
me, and MR. Left ventricular volumes (biplane modified
impson rule) and EF were measured from apical views.
eft atrial volume was calculated using the apical biplane
rea-length method (14,22) and indexed to body surface
rea (LA index). Left atrium is enlarged with LA index40
l/m2, a threshold previously defined in a normal popula-
ion (14). Accordingly, patients were stratified in 3 sub-
roups, as LA index within normal range (40 ml/m2, n 
58), mildly enlarged LA index (40 to 59 ml/m2, n  160),
nd severely enlarged LA index (60 ml/m2, n  174).
Mitral regurgitation was quantified by at least 2 of 3
alidated methods, averaged to calculate regurgitant volume
RVol) and effective regurgitant orifice area (ERO). Meth-
ds used were the proximal-isovelocity-surface-area method
23) in 391 patients, quantitative Doppler method (using
itral and aortic stroke volumes) in 485 and quantitative e-dimensional method (using
V volumes and aortic stroke
olume) in all patients (22). Be-
ause ERO was not measurable
n 32 patients, RVol, which has
imilar prognostic value as ERO
8) and was consistently measur-
ble in all patients, was used as
easure of MR severity (mild
R:30 ml/beat, moderate MR:
0 to 59 ml/beat, and severe MR:
60 ml/beat) (24). Mitral flow
rofile recorded, from apical views
t leaflets’ tips, diastolic E and A
elocities, E-wave deceleration
ime, and E/A ratio. Tricuspid regurgitant velocity
continuous-wave Doppler) allowed calculation of pulmonary
rtery systolic pressure.
linical assessment and follow-up. Baseline clinical char-
cteristics were recorded at diagnosis. Symptomatic patients
ere those with frank dyspnea with exercise or at rest.
oronary disease diagnosis was based on a history of
yocardial infarction or on angiography during the episode
f care. Integrated Charlson comorbidity score was calcu-
ated. Clinical outcome was monitored by return visits,
ailed questionnaires, review of medical records, and by
elephone calls to patients, referring cardiologists, and
rimary care physicians. The patient’s personal physician
sing all information available conducted, independently of
nvestigators, clinical management and decided follow-up
nd surgical timing, guided by available recommendations.
ause of death was classified as cardiovascular or noncar-
iovascular according to death certificates, next-of-kin in-
erview, and hospital and autopsy records. Congestive heart
ailure was diagnosed during follow-up using a combination
f major and minor criteria recommended by the Framing-
am Heart Study (25). Electrocardiogram confirmation of
F was required.
tatistical analysis. Continuous variables are summarized
s mean  SD and compared between groups using 1-way
nalysis of variance or Student t tests. Post hoc comparisons
sed Bonferroni tests. Non-normally distributed variables
Charlson index) comparisons used nonparametric Kruskal-
allis test. Categorical data were compared using chi-
quare tests. End points with conservative management
ere overall survival and combined cardiac events end point
cardiac death/AF/congestive heart failure), with follow-up
ensored at mitral surgery if performed. Surgery’s effect on
utcome was analyzed as time-dependent covariate using the
ntire follow-up, and survival curves were constructed accord-
ngly. Event rates, estimated using Kaplan-Meier method,
ere compared using log-rank test. Observed mortality was
ompared to that expected in the U.S. population using
og-rank test. Univariate and multivariate Cox proportional
azards analyzed LA index prediction of mortality and cardiac
Abbreviations
and Acronyms
AF  atrial fibrillation
EF  ejection fraction
ERO  effective regurgitant
orifice
LA  left atrium/atrial
LA index  left atrial
volume indexed to body
surface area
LV  left ventricle
MR  mitral regurgitation
RVol  regurgitant volumevents with calculation of hazard ratios (HRs). Multivariate
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Left Atrial Volume in Mitral Regurgitation August 10, 2010:570–8nalyses adjusted for known predictive variables (age, sex,
ymptoms, EF, regurgitant volume). A value of p  0.05 was
onsidered statistically significant.
esults
aseline characteristics. Baseline characteristics (Table 1)
emonstrate usual predominance of degenerative MR (pro-
apse in 81%, rheumatic in 5%, and miscellaneous in
emainder of patients), in older men with rare symptoms at
resentation. Mitral regurgitation grade was mild in 110
22%), moderate in 110 (22%), and severe in 272 (56%)
atients by quantitative criteria (24). Regurgitant volume
veraged 68  42 ml, ERO 42  29 mm2, LV diameter
ndex 31 4 mm/m2 (end diastole) and 194 mm/m2 (end
ystole), LA volume 103  49 ml, and LA index 55  26
l/m2. Left atrial index was 67  26 ml/m2 in severe MR
ompared with 47 16 ml/m2 (p 0.0001) in moderateMR.
edical therapy included angiotensin-converting enzyme in-
ibitors in 225 (46%) patients, angiotensin-receptor blocker in
10 (22%) patients, calcium-channel blocker in 135 (27%)
atients, diuretic in 188 (38%) patients, and beta-blocker in
77 (36%) patients.
Baseline characteristics stratified by LA index 40, 40 to
9, and 60 ml/m2 are shown Table 1. With higher LA
ndex, patients were older, were more often men and symp-
aseline Clinical and Echocardiographic Characteristics of thentire Patie t Population and Stratified by Categories of LA IndexTable 1 Baseli e Cli ical and Echo ardiograph c Charact risticEntire Patient Population and Stratified by Categories
All Patients
(n  492)
<4
(n 
Age, yrs 62 15 60
Men, n (%) 296 (60) 75 (
Symptoms, n (%) 44 (8.9) 1 (
BSA, m2 1.86 0.21 1.83
Systolic BP, mm Hg 135 19 136
Diastolic BP, mm Hg 79 10 78
Hypertension, n (%) 189 (38) 68 (
Coronary artery disease, n (%) 45 (9.1) 14 (
Valve prolapse, n (%) 398 (81) 98 (
RVol, ml/beat 68 42 37
ERO, mm2 42 29 22
LVD, mm 56 8 51
LVS, mm 34 7 31
LV mass, g/m2 113 27 95
LV EDVI, ml/m2 109 28 88
LV ESVI, ml/m2 34 14 28
EF, % 69 8 68
Mitral E-wave, cm/s 99 31 85
Mitral E/A 1.5 0.8 1.3
Mitral DT, ms 209 45 211
LA index, ml/m2 55 26 30
PASP, mm Hg 39 13 34
p  0.05 versus LA index 40 ml/m2; †p  0.0001 versus LA index 40 ml/m2; ‡p  0.05 ve
BP  blood pressure; BSA  body surface area, DT  deceleration time; EF  ejection fraction
ody surface area); LA index  left atrial volume indexed to body surface area; LVD  left ventricular end
urface area); LVS  left ventricular end-systolic diameter; PASP  pulmonary artery systolic pressure; Romatic, had more severe MR mostly related to prolapse, and
ad larger LV remodeling and hypertrophy. Despite LA
nlargement, higher LA index was associated with higher
ulmonary artery systolic pressure and early filling due to MR.
f note, patients with larger LA had no excess coronary
isease, comorbidity (Charlson index mean and 25% to 75%
uartiles: 0.75 [0 to 1], 0.82 [0 to 1], 0.78 [0 to 1] for LA index
40, 40 to 59, and 60, p  0.68) or hypertension.
A index and survival. During follow-up, 54 patients died
nder conservative management (5-year survival: 80 
.9%) and 35 of cardiovascular cause (5-year cardiovascular
ortality: 14  2.6%). In univariate analysis (Table 2), LA
nlargement strongly predicted mortality under conservative
anagement (HR: 1.3 [95% confidence interval (CI): 1.2 to
.5] per 10 ml/m2 LA index increment, p  0.0001),
pecifically with LA index 60 ml/m2 but not significantly
ith LA index 40 to 59 ml/m2. Patients with LA index60
l/m2 incurred lower 5-year survival (53 8.6%) compared
ith LA index 40 to 59 ml/m2 (84 4.8%) and40 ml/m2
90  3%, p  0.0001) (Fig. 1). Difference in survival
etween LA index 40 to 59 and 40 ml/m2 did not reach
ignificance (p  0.26).
Comparison to expected survival in the population
howed no difference with LA index 40 ml/m2 (expected
8%, p  0.81) or 40 to 59 ml/m2 (expected 86%, p 
the
Index
LA Index, ml/m2
p Value
40 to 59
(n  160)
>60
(n  174)
62 15 65 14* 0.003
97 (61)* 124 (71)†‡ 0.0001
12 (7.5)* 31 (18)†‡ 0.0001
1.87 0.21 1.88 0.21 0.08
134 18 133 18 0.37
77 9 76 10 0.23
62 (39) 59 (34) 0.44
12 (7.5) 19 (10) 0.80
137 (86)† 163 (94)†‡ 0.0001
65 32† 100 42†§ 0.0001
38 22† 63 30†§ 0.0001
56 6† 61 8†§ 0.0001
35 6† 37 7†‡ 0.0001
114 23† 128 24†§ 0.0001
107 23† 130 25†§ 0.0001
32 13* 39 15†§ 0.0001
71 8* 70 8 0.03
96 31* 115 30†§ 0.0001
1.5 0.9 1.8 0.8†‡ 0.0001
210 46 206 47 0.59
49 6 83 21 —
35 8 45 16†‡ 0.0001
index 40 to 59 ml/m2; §p  0.0001 versus LA index 40 to 59 ml/m2.
effective regurgitant orifice; ESVI  left ventricular end-systolic volumes indexed (normalized tos of
of LA
0
158)
15
48)
0.6)
0.21
21
10
43)
8.9)
62)
27
16
6
5
24
19
10
8
24
0.5
41
6
6
rsus LA
; ERO -diastolic diameter; LV EDVI  left ventricular end-diastolic volumes indexed (normalized to body
Vol  regurgitant volume.
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August 10, 2010:570–8 Left Atrial Volume in Mitral Regurgitation.90). However, survival was significantly lower than ex-
ected in patients with LA index 60 ml/m2 (expected
6%, p  0.017).
In multivariate analysis, adjusting for age, sex, symptoms,
F, and regurgitant volume, LA index independently pre-
icted survival (HR: 1.3 [95% CI: 1.1 to 1.5] per 10 ml/m2
ncrement and 2.8 [95% CI: 1.2 to 6.5] for LA index 60
l/m2) (Table 2). After further adjustment for Charlson
omorbidity index, LA index predictive value remained
nchanged (HR: 2.9 [95% CI: 1.3 to 6.7], p  0.009).
A index and cardiac events. During follow-up with
edical management, 32 patients experienced new onset of
F (5-year: 10.9 2.1%) and 49 patients experienced heart
ailure (5-year: 16.9 2.6%). Thus, 86 patients experienced
cardiac event (5-year: 28  3%) during follow-up under
onservative management.
Risk of Death and Cardiac Events Among PatienChronic Organic MR in Sinus Rhyth Under MTable 2 Risk of Death and Cardiac Ev nts AChronic Organic MR in Sinus Rhyth
HR (95%
Unadjusted
Per 10 ml/m2 increment in LA index 1.3 (1.2–1
LA index 40 to 59 ml/m2* 1.5 (0.97–
LA index  60 ml/m2* 4.2 (2.2–8
Adjusted†
Per 10 ml/m2 increment in LA index 1.3 (1.1–1
LA index 40 to 59 ml/m2* 1.4 (0.7–3
LA index 60 ml/m2* 2.8 (1.2–6
Cardiac events are defined as death from cardiovascular causes, he
patients with a LA index 40 ml/m2. †HRs adjusted for age, sex, sym
CI  confidence interval; HR  hazard ratio; LA index  left atrial v
Figure 1 Survival After Diagnosis According to LA Volume
Survival after diagnosis under medical management in patients with organic
mitral regurgitation in sinus rhythm at baseline according to stratification by left
atrial volume indexed to body surface area (left atrial index 40, 40 to 59, or
60 ml/m2). Note that patients with left atrial index 60 ml/m2 incur lower
survival than patients with smaller left atrium and also incur excess mortality
compared with that expected in the normal population (5-year observed sur-
vival: 53% vs. 76% expected, p  0.017). LA index  left atrial volume
indexed to body surface area.In univariate analysis (Table 2), LA enlargement strongly
redicted cardiac events under conservative management.
atients with LA index 60 ml/m2 had frequent cardiac
vents (5-year: 63  8%) versus 40 to 59 ml/m2 (31  6%)
nd 40 ml/m2 (9.7  3%, p  0.0001) (Fig. 2). Patients
ith LA index 40 to 59 ml/m2 had cardiac events more
requent than with LA index 40 ml/m2 (p  0.002) but
ower than with LA index 60 ml/m2 (p  0.0001).
In multivariate analysis, adjusting for age, sex, symptoms,
F, and regurgitant volume, LA index independently
redicted cardiac events under conservative management
Table 2). The LA index link to cardiac events remained
nchanged after further adjustment for Charlson comorbidity
ndex (HR: 5.4 [95% CI: 2.7 to 11.0] for LA index 60
l/m2), coronary artery disease, LV mass, or pulmonary
ressure (all p  0.0001).
ithManagementg Patients With
der Medical Management
th Cardiac Event
p Value HR (95% CI) p Value
0.0001 1.4 (1.3–1.5) 0.0001
0.29 2.1 (1.1–3.8) 0.026
0.0001 6.7 (3.9–11.8) 0.0001
0.001 1.3 (1.1–1.5) 0.0001
0.34 2.8 (1.5–5.5) 0.001
0.016 5.2 (2.6–10.9) 0.0001
re, and atrial fibrillation. *The reference group was made-up of the
, ejection fraction, and regurgitant volume.
indexed to body surface area; MR  mitral regurgitation.
Figure 2 Cardiac Events After
Diagnosis According to LA Volume
Rates of cardiac events (cardiac death, atrial fibrillation, or congestive heart
failure) after diagnosis under medical management in patients with organic
mitral regurgitation in sinus rhythm at baseline according to stratification by left
atrial volume indexed to body surface area (left atrial index 40, 40 to 59, or
60 ml/m2). Note that all event rates are significantly different from each
other (all p  0.01). Abbreviation as in Figure 1.ts Wdicalmon
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Left Atrial Volume in Mitral Regurgitation August 10, 2010:570–8ubgroup analysis. Outcome analysis was stratified by
Vol and LA index. Among 110 patients with RVol 30 to
9 ml, 18 had LA index 60 and 92 LA index 60 ml/m2,
nd among 272 patients with RVol 60 ml/beat, 151 had
A index 60 and 121 LA index 60 ml/m2.
Higher mortality under conservative management asso-
iated with LA index 60 ml/m2 was considerable in
atients with RVol 60 ml/beat (5-year: 54  10% vs.
0  6%, p  0.0009) but did not reach significance with
Vol 30 to 59 ml/beat (5-year: 38  18% vs. 17  6%, p 
.39) (Fig. 3). In patients with RVol60 ml/beat, observed
ong-term mortality was higher than expected with LA
ndex 60 ml/m2 (expected 27%, p  0.041) but was not
ifferent with LA index 60 ml/m2 (expected 16%, p 
.11). Similarly, with RVol 30 to 59, observed long-term
ortality was higher than expected with LA index 60
l/m2 (expected 19%, p  0.0023) but was not different
ith LA index 60 ml/m2 (expected 14%, p  0.72).
Cardiac events were more frequent with LA index 60
l/m2 whether they had RVol 60 ml/beat (5-year: 62 
% vs. 31  9%, p  0.0014) or 30 to 59 ml/beat (5-year:
9  13% vs. 17  5%, p  0.0001) (Fig. 4).
Patients with severe MR (RVol 60 ml/beat) and symp-
oms or EF 60% (n  52) were followed medically for
.5  1.16 years and surgery was delayed because patients
ere initially felt to be well under medical treatment.
xcluding these patients, and analyzing only patients without
lass I surgical indication by guidelines, results were un-
hanged. Indeed, LA index predicted mortality (HR: 1.25
95%CI: 1.07 to 1.44] per 10ml/m2, p 0.01 or 2.9 [95%CI:
.24 to 6.5] for LA index60 ml/m2, p 0.015) and cardiac
vents (HR: 1.29 [95% CI: 1.15 to 1.44] per 10 ml/m2, p 
Figure 3 Mortality Associated With LA Enlargement, Stratified
Overall mortality under medical management according to left atrial index (60 or
at baseline. Note that mortality is particularly in patients with both severe mitral regur.0001 or 5.4 [95% CI: 2.6 to 11.4] for LA index60 ml/m2, ( 0.0001 and 2.8 [95% CI: 1.5 to 5.4] for LA index 40 to
9 ml/m2, p  0.001).
itral valve surgery and outcome. Mitral surgery was
ltimately performed in 265 patients, involving valve repair
n 240 patients (90.6%) and valve replacement in 25 patients
mechanical: n  18, bioprosthesis: n  7). Forty patients
15.1%) underwent concomitant coronary bypass surgery
nd 7 had a Maze procedure. As expected, patients who
nderwent surgery after diagnosis versus those who re-
ained medically managed, had larger RVol (89  37 ml
s. 43  32 ml, p  0.001) and LA index (63  25 ml/m2
s. 46  23 ml/m2, p  0.001). During total follow-up
including pre- and post-operative period), 80 patients died
survival: 85 1.8% 5 years after diagnosis), and 26 patients
ied after mitral surgery (survival: 91  2.0% 5 years after
urgery). New onset AF occurred in 26 patients and heart
ailure in 15 patients. There was no difference in post-
perative outcome after stratification by pre-operative LA
ndex 60 or 60 ml/m2 (5-year post-operative mortality:
.1  2.0% vs. 8.7  2.8%, p  0.98; and cardiovascular
vents: 20  3.9% vs. 16.8  3.9%, p  0.34).
Cox proportional hazards analysis with mitral surgery as
ime-dependent covariate demonstrated that surgery was
ssociated with improved survival univariately (HR: 0.46
95% CI: 0.29 to 0.75]; p  0.0016). Accounting for the
ounger age and more frequent male sex of operated
atients, in multivariate analysis adjusted for age, sex,
ymptoms, regurgitant volume, EF, and LA index, mitral
urgery remained associated with improved survival (HR:
.46 [95% CI: 0.26 to 0.84]; p  0.01). Likewise, surgery
as associated with decreased cardiac events univariately
egurgitant Volume
l/m2) in patients with moderate (A) or severe (B) mitral regurgitation
and severe left atrial enlargement. Abbreviation as in Figure 1.by R
60 m
gitationHR: 0.56 [95% CI: 0.37 to 0.83]; p  0.0045) and after
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August 10, 2010:570–8 Left Atrial Volume in Mitral Regurgitationdjustment (0.38 [95% CI: 0.23 to 0.62]; p  0.0001). In
atients with LA index 60 ml/m2, mitral surgery (as
ime-dependent variable) was particularly beneficial com-
ared with medical management, with decreased mortality
9  3% vs. 47  9%; HR: 0.19 [95% CI: 0.09 to 0.38];
 0.001) (Fig. 5A) and cardiac events (22  5% vs. 63 
%; HR: 0.22 [95% CI: 0.12 to 0.39]; p 0.001) (Fig. 5B).
Figure 5 Outcome in Patients With Markedly Enlarged LA Com
Overall mortality (A) and cardiac events (B) over the entire follow-up compared be
variable) and medical management in patients with LA index 60 ml/m2 at baseli
to the surgical approach in these patients with markedly dilated LA. Abbreviation a
Figure 4 Cardiac Events Associated With LA Enlargement, Stra
Rates of cardiac events (cardiac death, atrial fibrillation, or congestive heart failure) un
with moderate (A) or severe (B) mitral regurgitation at baseline. Note that in moderat
event rates. Abbreviation as in Figure 1.iscussion
he present prospective study focused on the influence of
A enlargement on prognosis in patients with organic MR
n sinus rhythm at diagnosis. In this large cohort of patients
ith organic MR, we observed that baseline LA index
trongly and independently predicts survival in patients with
Between Surgical and Medical Management
surgical management performed during follow-up (surgery is a time-dependent
te that for both mortality and cardiac events, there is a marked outcome benefit
gure 1.
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arked LA enlargement (LA index 60 ml/m2) is associ-
ted with excess mortality in patients with organic MR
ompared with expected mortality in the population. Left
trial index is also a powerful predictor of cardiac events
cardiac death, congestive heart failure, AF) under medical
anagement with moderate or severe MR. Mitral surgery is
ssociated with improvement of outcome, particularly in
atients with LA index 60 ml/m2. Importantly, although
arked LA enlargement is a marker of high risk under
edical management, it is not associated with untoward
ffects after mitral surgery, so that it allows restoration of life
xpectancy after surgical correction of MR. Therefore,
ssessment of LA enlargement by measuring LA index
hould be performed routinely in patients with organic MR
nd used in considering surgical treatment.
nfluence of MR on LA remodeling. Left atrial enlarge-
ent is frequent in chronic organic MR (2,14,20), is
rogressive (12,26), and is understood as compensatory
esponse to volume overload (11,12,14), resulting in in-
reased atrial compliance and contributing to persistently
ormal atrial and pulmonary pressures (11,12). Hence,
rogressive LA enlargement due to organic MR is consid-
red as a mechanism delaying occurrence of symptoms and
eart failure.
In the present study, patients with higher LA enlarge-
ent had higher RVol and LV volumes, confirming its
eneral link to the volume overload due to MR, which
licits LA (2,14,20,27) and LV remodeling (28,29) in
rganic MR. However, there is considerable individual
ariability in LA enlargement, which is potentially linked to
V diastolic impairment (30) and end-diastolic pressure
levation (29) that affect LA pressure and further remodel-
ng (31). Whereas normal LA is compliant with low
ressure, it stretches and stiffens with chronic stress (32).
rganic MR induces LA remodeling with atrial interstitial
brosis experimentally (33) and in humans seen at a late
tage (34) impairing LA elastic properties and compliance
ith elevated LA pressure (11,29,35,36). Indeed, in organic
R, higher LA enlargement is associated with paradoxi-
ally higher pulmonary pressure (14) and with marked
ormonal (B-natriuretic peptide) activation (37) and re-
uced functional capacity (38). Hence, marked LA enlarge-
ent is not just a benign compensatory mechanism but
ikely reflects severe consequences of volume overload in
rganic MR with important implications for outcome.
A enlargement and outcome in organic MR. The size
f LA is considered a predictor of AF occurrence (15),
hich is logical but is potentially tainted by the fact that LA
nlargement may be the consequence of previous undetected
aroxysmal AF (14). However, it is more consequential that
A enlargement predicts poor outcomes in various clinical
18,19) or epidemiological (16,17,39) circumstances. In
rganic MR, LA enlargement predicts future AF (14,20,21)
nd limited observations suggest that it is associated with
ubsequent occurrence of heart failure (2). The present ptudy confirms and most importantly extends these obser-
ations by demonstrating for the first time the strong value
f LA index measured at diagnosis, in predicting death or
ardiac events under conservative management, indepen-
ently of known outcome predictors in patients with organic
R in sinus rhythm at diagnosis.
Patients with LA index60 ml/m2 incur excess mortality
nder medical management compared with the U.S. popu-
ation and compared with patients with MR and lower LA
nlargement, even after adjustment and stratification by
Vol. Furthermore, LA index60 ml/m2 also strongly and
ndependently predicts cardiac events with medical manage-
ent, even after adjustment and stratification by RVol. Less
evere LA enlargement (LA index 40 to 59 ml/m2) had less
otable consequences on survival after diagnosis. Severe LA
nlargement, complicating severe or even moderate regur-
itation, is thus a harbinger of poor outcome in patients
ith organic MR, even in those without symptoms and with
reserved LVEF. Therefore, LA volume should be part of
omprehensive echocardiographic examination and should
e used in considering surgical treatment in patients with
evere organic MR.
ffect of surgery on prognosis. Mitral valve surgery im-
roves symptoms and outcome in symptomatic patients
ith severe chronic MR, particularly with valve repair (3,4).
lass I indications for surgery are based on symptoms or LV
ysfunction in current guidelines (3,4). Nevertheless, opti-
al timing of surgery in organic MR remains debated
3,4,7–9). Indeed, patients operated on after they become
ymptomatic or after developing LV dysfunction incur
xcess mortality after surgery (5,6) so that such rescue
urgery leaves patients with less than optimal result. Thus,
ngoing research aims at defining markers of outcome that
re associated with notable risk under medical management
ut do not affect post-operative outcome and allow life
xpectancy restoration after surgery. Recent data demon-
trated improvement of outcome after surgery, particularly
alve repair, resulting in restoration of life expectancy in
atients with severe MR (2,8,9), even in patients asymp-
omatic before surgery (8). The present study confirms
eneficial effects of mitral surgery on mortality and cardiac
vents, emphasizing patients with marked LA enlargement
nd importantly, shows that LA enlargement does not
mply untoward post-operative outcome. Thus, in contrast
o symptoms or low EF, LA index60 ml/m2 is a high-risk
arker allowing restorative surgery without excess post-
perative risk.
In clinical practice, our data suggest that LA index 60
l/m2 should be included among novel markers of risk in
rganic MR in conjunction with MR severity quantitation
8) as part of comprehensive risk assessment. In view of the
isk attached to marked LA enlargement and of outcome
mprovement provided by surgery, we believe that patients
ith severe MR and LA index 60 ml/m2, even those
symptomatic, should be considered for mitral surgery,
articularly if valve repair is feasible. Conversely, patients
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August 10, 2010:570–8 Left Atrial Volume in Mitral Regurgitationith moderate MR incur initially lower risks (8) and LA
ndex 60 ml/m2 should lead to close follow-up to detect
R progression.
tudy limitations. Our study strength relies on triple
uantitative assessment of LV, LA, and MR with prospec-
ive enrollment of patients with organic MR in sinus
hythm. Atrial fibrillation is an important determinant of
A remodeling per se, which we excluded and the role of
A enlargement in patients with MR and AF will require
uture studies.
Clinical management was determined independently by
atient’s personal physicians without investigators’ interfer-
nce. Regular follow-up, touted as key to good outcome (7),
as obtained in all patients, at Mayo Clinic or with their
ome physicians, and is representative of routine medical
are.
Left atrial enlargement is caused by MR and may be
onsidered a surrogate for MR severity. However, LA
nlargement integrates not only MR degree but also other
easures of the valve disease severity (14). The crucial point
s that LA index, irrespective of this supposed “surrogate”
ature, predicted survival and cardiac events, adjusting for
nown predictors of outcome in organic MR, including
harlson comorbidity index and quantitation of MR sever-
ty. In that respect adjustment by ERO did not affect results
HR for LA index 60: 2.48, p  0.036 for mortality and
.98, p  0.0001 for cardiac events). Overfitting may cause
etection of spurious predictors of outcome, but the pro-
pective and hypothesis-driven natures of our study that
sed few adjusting variables concur to suggest overfitting
isk as minimal. Thus, we believe that LA enlargement is
ndeed an integrator of MR consequences rather than a
urrogate, which should be used for risk stratification and
linical decisions in routine practice.
onclusions
n this large population of patients with chronic organic
R in sinus rhythm, LA enlargement is a strong and
ndependent predictor of outcome under medical manage-
ent, even after adjustment and stratification by regurgitant
olume. Patients with LA index 60 ml/m2 incur excess
ortality and frequent cardiac events whereas those with
A index 30 to 59 ml/m2 tend to present with notable
ardiac events. Mitral valve surgery results in improved
utcome, particularly in patients with a LA index 60
l/m2. Thus, LA volume measurement should be a part of
outine echocardiographic examination and be integrated
nto the clinical decision making process in patients with
rganic MR.
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